Dr Gordon Sanghera, CBE, is the CEO and co-founder of Oxford Nanopore Technologies, leading the company since 2005 in developing its groundbreaking nanopore-based sequencing platforms used worldwide for real-time DNA and RNA analysis, with expansion into proteomics and metabolomics on the horizon. Holding a PhD in bioelectronics and a BSc in chemistry from Cardiff University, he previously played a key role at MediSense in advancing glucose monitoring systems. Recognised for his global impact on biotechnology, he was appointed Commander of the Order of the British Empire in 2023.